Chong, G., Dickson, J. L. B., Cunningham, D., Norman, A. R., Rao, S., Hill, M. E., . . . Tebbutt, N. (2005). Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan. Nature Publishing Group.
Citação norma ChicagoChong, G., J L B. Dickson, D. Cunningham, A R. Norman, S. Rao, M E. Hill, T J. Price, J. Oates, and N. Tebbutt. Capecitabine and Mitomycin C As Third-line Therapy for Patients With Metastatic Colorectal Cancer Resistant to Fluorouracil and Irinotecan. Nature Publishing Group, 2005.
Citação norma MLAChong, G., et al. Capecitabine and Mitomycin C As Third-line Therapy for Patients With Metastatic Colorectal Cancer Resistant to Fluorouracil and Irinotecan. Nature Publishing Group, 2005.